Clearstead Advisors, LLC Procept Bio Robotics Corp Transaction History
Clearstead Advisors, LLC
- $7.4 Billion
- Q3 2025
A detailed history of Clearstead Advisors, LLC transactions in Procept Bio Robotics Corp stock. As of the latest transaction made, Clearstead Advisors, LLC holds 597 shares of PRCT stock, worth $17,724. This represents 0.0% of its overall portfolio holdings.
Number of Shares
597
Previous 360
65.83%
Holding current value
$17,724
Previous $20,000
5.0%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding PRCT
# of Institutions
272Shares Held
49.1MCall Options Held
274KPut Options Held
376K-
Vanguard Group Inc Valley Forge, PA5.21MShares$155 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.49MShares$103 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY3.42MShares$102 Million0.04% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD2.05MShares$60.9 Million0.04% of portfolio
-
Westfield Capital Management CO LP Boston, MA1.97MShares$58.5 Million0.32% of portfolio
About PROCEPT BioRobotics Corp
- Ticker PRCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 44,592,300
- Market Cap $1.32B
- Description
- PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...